Breaking News Instant updates and real-time market news.

2020-11-18 12:27:31 IONS Ionis Pharmaceuticals $52.02 / -0.52 (-0.99%) 12:27 11/18/20 11/18 12:27 11/18/20 12:27	Ionis Pharmaceuticals participates in a conference call with JPMorgan SMid Cap Biotech Analyst Fye holds a conference call with CEO Monia and CFO Hougen on November 18 at 2 pm hosted by JPMorgan.
IONS Ionis Pharmaceuticals $52.02 / -0.52 (-0.99%) 09/23/20 BMO Capital Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO 09/23/20 SVB Leerink Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink 09/22/20 Cantor Fitzgerald Ionis Pharmaceuticals price target raised to $59 from $56 at Cantor Fitzgerald 09/14/20 JPMorgan Ionis Pharmaceuticals resumed with a Neutral at JPMorgan

2020-11-18 12:27:31

IONS

Ionis Pharmaceuticals

$52.02 / -0.52 (-0.99%)

12:27

11/18/20

11/18

12:27

11/18/20

12:27

Ionis Pharmaceuticals participates in a conference call with JPMorgan

SMid Cap Biotech Analyst Fye holds a conference call with CEO Monia and CFO Hougen on November 18 at 2 pm hosted by JPMorgan.

IONS Ionis Pharmaceuticals

$52.02 / -0.52 (-0.99%)

09/23/20 BMO Capital: Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO

09/23/20 SVB Leerink: Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink

09/22/20 Cantor Fitzgerald: Ionis Pharmaceuticals price target raised to $59 from $56 at Cantor Fitzgerald

09/14/20 JPMorgan: Ionis Pharmaceuticals resumed with a Neutral at JPMorgan

TODAY'S FREE FLY STORIES

General news	, with core yields now about 1 bp to 2.4 bps richer as many stock markets » 07:45 01/25/21 01/25 07:45 01/25/21 07:45 Treasury Market Outlook:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Cowen Group appoints Kelly Wiegel to management committee » 07:44 01/25/21 01/25 07:44 01/25/21 07:44 COWN Cowen Group $27.22 / -0.49 (-1.77%) Cowen announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events COWN Cowen Group $27.22 / -0.49 (-1.77%) 12/02/20 Cowen, Intrepid Partners expand strategic alliance agreement 10/27/20 Cowen Group raises quarterly dividend to 8c per share 09/15/20 Cowen Group to acquire investment banking business of MHT Partners 08/03/20 Cowen Group leads $10M Series A financing round in Kyber Data Science COWN Cowen Group $27.22 / -0.49 (-1.77%) 12/02/20 JMP Securities Cowen Group price target raised to $32 from $25 at JMP Securities 11/23/20 Piper Sandler Cowen Group price target raised to $35 from $25 at Piper Sandler 07/22/20 Wolfe Research Cowen Group initiated with an Outperform at Wolfe Research COWN Cowen Group $27.22 / -0.49 (-1.77%) 10/27/20 Cowen Group reports Q3 economic EPS $1.25, consensus 38c 07/28/20 Cowen Group reports Q2 economic EPS $5.69, consensus $4.76 02/11/21 Cowen Group - COWN
Hot Stocks	OFG Bancorp: Q4 results reflect pre-tax merger, restructuring charges of $10.1M 07:44 01/25/21 01/25 07:44 01/25/21 07:44 OFG OFG Bancorp $19.19 / + (+0.00%) ShowHide Related Items >><< Earnings Events OFG OFG Bancorp $19.19 / + (+0.00%) 07:35 Today OFG Bancorp reports Q4 EPS 42c, two estimates 45c 10/23/20 OFG Bancorp reports Q3 EPS 50c, consensus 35c 10:00 Today OFG Bancorp - OFG
Hot Stocks	Kimberly-Clark CEO sees 'higher commodity costs' in 2021 » 07:44 01/25/21 01/25 07:44 01/25/21 07:44 KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) Chairman and CEO Mike Hsu… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 07:35 Today Kimberly-Clark sees FY21 Share repurchases of $650M-$750M 07:35 Today Kimberly-Clark announces 6.5% increase in quarterly dividend to $1.14 per share 07:33 Today Kimberly-Clark sees FY21 CapEx $1.2B-$1.3B 07:32 Today Kimberly-Clark announces 6.5% increase in quarterly dividend KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 01/21/21 Deutsche Bank Kimberly-Clark price target lowered to $144 from $150 at Deutsche Bank 01/19/21 Bernstein Kimberly-Clark initiated with a Market Perform at Bernstein 12/07/20 Wells Fargo Kimberly-Clark initiated with an Underweight at Wells Fargo 10/16/20 Fly Intel: Top five analyst initiations KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 07:33 Today Kimberly-Clark sees FY21 adjusted EPS $7.75-$8.00, consensus $7.77 07:30 Today Kimberly-Clark reports Q4 adjusted EPS $1.69, consensus $1.60 10/22/20 Kimberly-Clark raises FY20 net sales growth view to 2%-3% from 1%-2% 10/22/20 Kimberly-Clark raises FY20 adj. EPS view to $7.50-$7.65 from $7.40-$7.60 KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/22/20 Fly Intel: Wall Street's top stories for Thursday 10/22/20 Fly Intel: Wall Street's top stories at midday 10/22/20 Fly Intel: Pre-market Movers 10:00 Today Kimberly-Clark - KMB
Hot Stocks	Revival Gold extends Haidee Zone with 2020 drilling results » 07:43 01/25/21 01/25 07:43 01/25/21 07:43 RVLGF Revival Gold $0.00 / + (+0.00%) Revival Gold is pleased… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research RVLGF Revival Gold $0.00 / + (+0.00%) 12/10/20 Revival Gold intersects near-surface oxide gold in holes at Beartrack-Arnett 11/17/20 Revival Gold announces results from PEA on Beartrack-Arnett phase one project 11/12/20 Revival Gold announces results from additional five drill holes 10/15/20 Revival Gold reports results from first seven drill holes from 2020 campaign RVLGF Revival Gold $0.00 / + (+0.00%) 08/28/20 PI Financial Revival Gold price target lowered to C$1.35 from C$1.40 at PI Financial

Hot Stocks	Ucommune International announces additional investment in Xiyu Information » 07:43 01/25/21 01/25 07:43 01/25/21 07:43 UK Ucommune International $4.87 / -0.115 (-2.31%) Ucommune International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Schrodinger price target raised to $117 from $97 at BMO Capital » 07:42 01/25/21 01/25 07:42 01/25/21 07:42 SDGR Schrodinger $95.64 / +0.87 (+0.92%) BMO Capital analyst Do… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SDGR Schrodinger $95.64 / +0.87 (+0.92%) 01/19/21 David E Shaw reports 17.2% passive stake in Schrodinger 12/07/20 Schrodinger presents data from MALT1 inhibitor program at ASH 11/23/20 Schrodinger jumps 7% to $64.90 after announcing collaboration with Bristol-Myers 11/23/20 Schrodinger announces discovery collaboration with Bristol-Myers SDGR Schrodinger $95.64 / +0.87 (+0.92%) 11/23/20 BofA BofA upgrades Schrodinger to Buy after 'major' collaboration announcement 11/23/20 BofA Schrodinger upgraded to Buy from Neutral at BofA 10/12/20 Jefferies Schrodinger upgraded to Buy from Hold at Jefferies 08/10/20 Schrodinger files to sell 4.5M shares of common stock SDGR Schrodinger $95.64 / +0.87 (+0.92%) 11/12/20 Schrodinger reports Q3 EPS 5c, consensus (7c) 08/10/20 Schrodinger reports Q2 EPS (5c), consensus (28c) 13 Aug 06 Feb SDGR Schrodinger $95.64 / +0.87 (+0.92%) 10/26/20 Fly Insider: Selecta, Netflix among week's notable insider trades 08/10/20 Fly Intel: Wall Street's top stories for Monday 08/10/20 Fly Intel: Wall Street's top stories at midday 08/10/20 Fly Intel: Pre-market Movers SDGR Schrodinger $95.64 / +0.87 (+0.92%) 10/30/20 Largest borrow rate increases among liquid names
Hot Stocks	Philips' Stellarex drug-coated balloon meets safety goals in two studies » 07:42 01/25/21 01/25 07:42 01/25/21 07:42 PHG Philips $55.60 / +0.22 (+0.40%) Royal Philips announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PHG Philips $55.60 / +0.22 (+0.40%) 05:22 Today Philips, Rennes University Hospital announce five-year partnership 05:13 Today Philips, Vithas Group enter five-year innovation and collaboration agreement 01/19/21 Philips to acquire Capsule Technologies for $635M in cash, sees accretion 01/14/21 Philips. Merck partner on personalized fertility treatment solutions PHG Philips $55.60 / +0.22 (+0.40%) 07:03 Today Morgan Stanley iRhythm price target raised to $288 from $227 at Morgan Stanley 01/20/21 Berenberg Philips price target raised to EUR 50 from EUR 49 at Berenberg 01/19/21 JPMorgan Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan 11/12/20 Berenberg Philips price target raised to EUR 49 from EUR 46 at Berenberg PHG Philips $55.60 / +0.22 (+0.40%) 05:32 Today Philips reports Q4 adjusted EPS EUR 0.94 vs. EUR 0.83 last year 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year PHG Philips $55.60 / +0.22 (+0.40%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says PHG Philips $55.60 / +0.22 (+0.40%) 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers 09/05/20 Week in review: How Trump's policies moved stocks 03/02/21 2021 London Global Healthcare Virtual Conference 16:00 Today Philips - PHG
Earnings	OptimizeRx sees 2020 revenue approx. $43M, consensus $37.99M » 07:41 01/25/21 01/25 07:41 01/25/21 07:41 OPRX OptimizeRx $44.66 / +1.63 (+3.79%) Up 75% over 2019.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 12/07/20 OptimizeRx, Komodo Health partner to expand life sciences support 12/01/20 OptimizeRx launches AI-powered, real-world evidence solution for PoC platform 11/11/20 OptimizeRx appoints Angelo Campano as SVP, principal of agency channels 09/15/20 OptimizeRx expands direct-to-patient reach in partnership with Epion Health OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 01/07/21 Lake Street OptimizeRx price target raised to $40 from $26 at Lake Street 01/07/21 Roth Capital OptimizeRx price target raised to $70 from $40 at Roth Capital 01/04/21 B. Riley Securities OptimizeRx price target raised to $50 from $34 at B. Riley Securities 11/11/20 B. Riley Securities OptimizeRx price target raised to $34 from $30 at B. Riley Securities OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 07:40 Today OptimizeRx sees Q4 revenue approx. $16M, consensus $11.1M 11/09/20 OptimizeRx reports Q3 EPS 7c, consensus 4c 10/20/20 OptimizeRx sees Q3 revenue exceeding $10M, consensus $9.77M 10/13/20 OptimizeRx sees Q3 revenue exceeding $10M, consensus $9.1M OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 10/08/20 OptimizeRx falls after Seeking Alpha contributor sees 'inaccurate financials' 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	Axon to change Nasdaq symbol to 'AXON,' effective January 26 » 07:41 01/25/21 01/25 07:41 01/25/21 07:41 AAXN Axon $170.40 / +7.83 (+4.82%) , AXON Axon $0.00 / + (+0.00%) Axon announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly AAXN AAXN Axon $170.40 / +7.83 (+4.82%) 07:37 Today Axon to change Nasdaq symbol to 'AXON,' effective January 26 01/15/21 Los Angeles Police Department renews contract with Axon 01/12/21 DEA to negotiate on sole source basis with Axon for body worn cameras 12/16/20 Axon to equip Green Bay police with body and in-car cameras and Taser devices AAXN AXON AAXN Axon $170.40 / +7.83 (+4.82%) 01/15/21 Fly Intel: Top five analyst upgrades 01/15/21 Morgan Stanley Axon upgraded to Overweight on new market penetration at Morgan Stanley 01/15/21 Morgan Stanley Axon upgraded to Overweight from Equal Weight at Morgan Stanley 12/16/20 JMP Securities Axon cut to Market Perform at JMP Securities, sees stock as fairly valued AXON Axon $0.00 / + (+0.00%) AAXN AAXN Axon $170.40 / +7.83 (+4.82%) 11/05/20 Axon raises FY20 revenue to $630M-$640M from $625M-$635M, consensus $611.77M 11/05/20 Axon sees Q4 revenue $175M-$185M, consensus 08/06/20 Axon reports Q2 non-GAAP EPS 1c, consensus 16c 17 Jun AAXN AAXN Axon $170.40 / +7.83 (+4.82%) 10/29/20 Justice Department to lift ban on body cameras when working with feds, WSJ says AAXN AAXN Axon $170.40 / +7.83 (+4.82%) 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street 01/15/21 Fly Intel: Pre-market Movers

Hot Stocks	The9 signs investment agreement with Jianping Kong, others » 07:41 01/25/21 01/25 07:41 01/25/21 07:41 NCTY The9 $11.13 / +2.08 (+22.98%) , CAN Canaan $4.86 / +0.07 (+1.46%) The9 (NCTY) signed the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly Options NCTY CAN NCTY The9 $11.13 / +2.08 (+22.98%) 07:39 Today The9 signs MOUs on purchase of Bitcoin mining machines 01/04/21 The9 signs term sheet with mining investors to start cryptocurrencies business 11/17/20 The9 receives noncompliance notice from Nasdaq 11/03/20 The9 regains compliance with NASDAQ listing rules CAN Canaan $4.86 / +0.07 (+1.46%) 01/04/21 The9 signs term sheet with mining investors to start cryptocurrencies business 09/08/20 Canaan approves $10M share repurchase program 08/04/20 Canaan announces departure of directors Jianping Kong, Qifeng Sun 08/04/20 Canaan appoints four independent directors to board NCTY CAN NCTY The9 $11.13 / +2.08 (+22.98%) 01/04/21 Fly Intel: Wall Street's top stories for Monday 01/04/21 Fly Intel: Wall Street's top stories at midday 01/04/21 Fly Intel: Pre-market Movers CAN Canaan $4.86 / +0.07 (+1.46%) 11/19/20 Rising High: An exclusive talk with multi-state operator Orchid Ventures 09/08/20 Fly Intel: Pre-market Movers CAN CAN Canaan $4.86 / +0.07 (+1.46%) 01/06/21 Fifteen new option listings on January 6th
Earnings	OptimizeRx sees Q4 revenue approx. $16M, consensus $11.1M » 07:40 01/25/21 01/25 07:40 01/25/21 07:40 OPRX OptimizeRx $44.66 / +1.63 (+3.79%) Up 117% versus the fourth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 12/07/20 OptimizeRx, Komodo Health partner to expand life sciences support 12/01/20 OptimizeRx launches AI-powered, real-world evidence solution for PoC platform 11/11/20 OptimizeRx appoints Angelo Campano as SVP, principal of agency channels 09/15/20 OptimizeRx expands direct-to-patient reach in partnership with Epion Health OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 01/07/21 Lake Street OptimizeRx price target raised to $40 from $26 at Lake Street 01/07/21 Roth Capital OptimizeRx price target raised to $70 from $40 at Roth Capital 01/04/21 B. Riley Securities OptimizeRx price target raised to $50 from $34 at B. Riley Securities 11/11/20 B. Riley Securities OptimizeRx price target raised to $34 from $30 at B. Riley Securities OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 11/09/20 OptimizeRx reports Q3 EPS 7c, consensus 4c 10/20/20 OptimizeRx sees Q3 revenue exceeding $10M, consensus $9.77M 10/13/20 OptimizeRx sees Q3 revenue exceeding $10M, consensus $9.1M 08/05/20 OptimizeRx reports Q2 EPS 2c, consensus (3c) OPRX OptimizeRx $44.66 / +1.63 (+3.79%) 10/08/20 OptimizeRx falls after Seeking Alpha contributor sees 'inaccurate financials' 03/15/21 33rd Annual Roth Virtual Conference
Periodicals	Arrowhead files IND for study of ARO-ANG3 for treatment of mixed dyslipidemia » 07:40 01/25/21 01/25 07:40 01/25/21 07:40 ARWR Arrowhead $82.12 / +2.01 (+2.51%) Arrowhead Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ARWR Arrowhead $82.12 / +2.01 (+2.51%) 11/25/20 Arrowhead, Takeda Pharmaceutical close collaboration and license agreement 11/13/20 Arrowhead reports presentation of new clinical data at AHA 2020 11/13/20 Arrowhead announces interim clinical data from AROAAT2002 trial 10/13/20 Arrowhead's Mauro Ferrari sells 10,000 common shares ARWR Arrowhead $82.12 / +2.01 (+2.51%) 12/21/20 Baird Arrowhead near-term risks move Baird to the sidelines 12/21/20 Baird Arrowhead downgraded to Neutral from Outperform at Baird 12/15/20 UBS Arrowhead initiated with a Buy at UBS 11/24/20 RBC Capital Arrowhead price target raised to $80 from $62 at RBC Capital ARWR Arrowhead $82.12 / +2.01 (+2.51%) 11/23/20 Arrowhead reports FY20 EPS (84c), consensus (21c) 08/05/20 Arrowhead reports Q3 EPS (13c), consensus (12c) ARWR Arrowhead $82.12 / +2.01 (+2.51%) 07:39 Today Arrowhead files IND for study of ARO-ANG3 for treatment of mixed dyslipidemia ARWR Arrowhead $82.12 / +2.01 (+2.51%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 11/23/20 Fly Intel: After-Hours Movers 09/16/20 Fly Intel: Wall Street's top stories for Wednesday 09/16/20 Fly Intel: Wall Street's top stories at midday 02/04/21 Arrowhead - ARWR ARWR Arrowhead $82.12 / +2.01 (+2.51%) 11/23/20 Arrowhead options imply 6.2% move in share price post-earnings
Hot Stocks	Parsons to lead industry team to work with U.S. Air Forces in Europe and Africa » 07:39 01/25/21 01/25 07:39 01/25/21 07:39 PSN Parsons $38.55 / +0.35 (+0.92%) , LDOS Leidos $112.18 / +2.84 (+2.60%) , SAIC SAIC $101.05 / +1 (+1.00%) Parsons (PSN) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PSN LDOS SAIC PSN Parsons $38.55 / +0.35 (+0.92%) 12/28/20 Parsons selected for bridge expertise on Illinois projects totaling over $16M 12/17/20 Parsons awarded $20M task order 12/09/20 Parsons awarded $21M contract by Southern Nevada Water Authority 12/08/20 Parsons awarded $32M contract by San Bernardino County Transportation Authority LDOS Leidos $112.18 / +2.84 (+2.60%) 12/15/20 Leidos awarded FAA contract valued at up to $64M 12/10/20 Leidos to acquire IT and cloud solutions provider 1901 Group for $215M 11/23/20 Leidos awarded $82M contract by Naval Medical Logistics Command 11/17/20 3M awarded a contract by Leidos for U.S. DOD DHMSM initiative SAIC SAIC $101.05 / +1 (+1.00%) 11/05/20 SAIC names Prabu Natarajan CFO 11/04/20 SAIC wins spot on USDA contract for IT to farm and conservation agencies 10/29/20 SAIC wins $737M U.S. Air Force modeling, support services contract 10/26/20 SAIC awarded $750M task order from the Army National Guard PSN LDOS SAIC PSN Parsons $38.55 / +0.35 (+0.92%) 05/05/20 Wells Fargo Parsons price target raised to $39 from $33 at Wells Fargo 04/15/20 Benchmark Parsons initiated with a Buy at Benchmark 04/02/20 Wells Fargo Parsons price target lowered to $33 from $42 at Wells Fargo 03/30/20 William Blair Parsons initiated with an Outperform at William Blair LDOS Leidos $112.18 / +2.84 (+2.60%) 11/03/20 Credit Suisse Leidos price target lowered to $120 from $131 at Credit Suisse 09/23/20 Barclays Barclays upgrades Leidos to Overweight, sees above peer growth in 2021 09/23/20 Barclays Leidos upgraded to Overweight from Equal Weight at Barclays 09/22/20 JPMorgan Leidos upgraded to Overweight on bottomed estimates at JPMorgan SAIC SAIC $101.05 / +1 (+1.00%) 09/24/20 William Blair William Blair uncovers second large, unannounced contract win for SAIC 09/16/20 William Blair SAIC seems to have won 8th largest contract at $753M, says William Blair 09/08/20 JPMorgan SAIC removed from Analyst Focus List at JPMorgan 09/03/20 Citi SAIC price target raised to $105 from $100 at Citi PSN LDOS SAIC PSN Parsons $38.55 / +0.35 (+0.92%) 11/04/20 Parsons backs FY20 revenue view $3.95B-$4.05B, consensus $4.01B 11/04/20 Parsons reports Q3 adj. EPS 57c, consensus 33c 08/05/20 Parsons backs FY20 revenue view $3.95B-$4.05B, consensus $4.02B 08/05/20 Parsons reports Q2 adj. EPS 49c, consensus 29c LDOS Leidos $112.18 / +2.84 (+2.60%) 11/02/20 Leidos raises FY20 adjusted EPS view to $5.65-$5.85 from $5.25-$5.55 11/02/20 Leidos reports Q3 adjusted EPS $1.47, consensus $1.23 08/04/20 Leidos raises FY20 EPS view to $5.25-$5.55 from $5.00-$5.30, consensus $5.24 08/04/20 Leidos reports Q2 EPS $1.55, consensus $1.09 SAIC SAIC $101.05 / +1 (+1.00%) 12/03/20 SAIC narrows FY21 adj. EPS view to $5.95-$6.05 from $5.80-$6.10 12/03/20 SAIC reports Q3 adjusted EPS $1.62, consensus $1.53 09/02/20 SAIC backs FY21 adjusted EPS view $5.80-$6.10, consensus $6.13 09/02/20 SAIC reports Q2 adjusted EPS $1.63, consensus $1.44 PSN SAIC PSN Parsons $38.55 / +0.35 (+0.92%) 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades SAIC SAIC $101.05 / +1 (+1.00%) 09/02/20 Fly Intel: After-Hours Movers 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 02/23/21 Leidos - LDOS 02/24/21 Parsons - PSN
Periodicals	Arrowhead files IND for study of ARO-ANG3 for treatment of mixed dyslipidemia » 07:39 01/25/21 01/25 07:39 01/25/21 07:39 ARWR Arrowhead $82.12 / +2.01 (+2.51%) Arrowhead Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ARWR Arrowhead $82.12 / +2.01 (+2.51%) 11/25/20 Arrowhead, Takeda Pharmaceutical close collaboration and license agreement 11/13/20 Arrowhead reports presentation of new clinical data at AHA 2020 11/13/20 Arrowhead announces interim clinical data from AROAAT2002 trial 10/13/20 Arrowhead's Mauro Ferrari sells 10,000 common shares ARWR Arrowhead $82.12 / +2.01 (+2.51%) 12/21/20 Baird Arrowhead near-term risks move Baird to the sidelines 12/21/20 Baird Arrowhead downgraded to Neutral from Outperform at Baird 12/15/20 UBS Arrowhead initiated with a Buy at UBS 11/24/20 RBC Capital Arrowhead price target raised to $80 from $62 at RBC Capital ARWR Arrowhead $82.12 / +2.01 (+2.51%) 11/23/20 Arrowhead reports FY20 EPS (84c), consensus (21c) 08/05/20 Arrowhead reports Q3 EPS (13c), consensus (12c) ARWR Arrowhead $82.12 / +2.01 (+2.51%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 11/23/20 Fly Intel: After-Hours Movers 09/16/20 Fly Intel: Wall Street's top stories for Wednesday 09/16/20 Fly Intel: Wall Street's top stories at midday 02/04/21 Arrowhead - ARWR ARWR Arrowhead $82.12 / +2.01 (+2.51%) 11/23/20 Arrowhead options imply 6.2% move in share price post-earnings

Hot Stocks	The9 signs MOUs on purchase of Bitcoin mining machines » 07:39 01/25/21 01/25 07:39 01/25/21 07:39 NCTY The9 $11.13 / +2.08 (+22.98%) The9 announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly NCTY The9 $11.13 / +2.08 (+22.98%) 01/04/21 The9 signs term sheet with mining investors to start cryptocurrencies business 11/17/20 The9 receives noncompliance notice from Nasdaq 11/03/20 The9 regains compliance with NASDAQ listing rules 09/21/20 The9, Voodoo to collaborate on game publishing in mainland China NCTY The9 $11.13 / +2.08 (+22.98%) 01/04/21 Fly Intel: Wall Street's top stories for Monday 01/04/21 Fly Intel: Wall Street's top stories at midday 01/04/21 Fly Intel: Pre-market Movers
Recommendations	Kansas City Southern price target raised to $246 from $237 at Credit Suisse » 07:39 01/25/21 01/25 07:39 01/25/21 07:39 KSU Kansas City Southern / + Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KSU Kansas City Southern / + 01/20/21 Kansas City Southern, NorthPoint to develop Wylie Logistics Park in Texas 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 KSU Kansas City Southern / + 07:28 Today Benchmark Kansas City Southern transferred at Benchmark with unchanged Hold rating 07:19 Today Morgan Stanley Kansas City Southern price target raised to $200 from $142 at Morgan Stanley 07:11 Today Barclays Kansas City Southern price target raised to $235 from $220 at Barclays 01/15/21 Raymond James Kansas City Southern price target raised to $245 from $210 at Raymond James KSU Kansas City Southern / + 01/22/21 Kansas City Southern sees FY22 EPS $10.50-$11.00 01/22/21 Kansas City Southern sees FY21 EPS at least $9.00, consensus $8.51 01/22/21 Kansas City Southern reports Q4 EPS $1.80, consensus $1.92 01/21/21 Notable companies reporting before tomorrow's open KSU Kansas City Southern / + 11/10/20 Kansas City Southern potential bidders have moved on, CNBC reports 09/09/20 Kansas City Southern rejects $20B buyout bid from PE suitors, WSJ says 09/09/20 Kansas City Southern rejects $20B buyout bid from PE suitors, WSJ says 09/02/20 Blackstone, GIP make bid to buy Kansas City Southern, WSJ says KSU Kansas City Southern / + 09/10/20 Fly Intel: Wall Street's top stories for Thursday 09/10/20 Fly Intel: Wall Street's top stories at midday 09/09/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: Wall Street's top stories for Wednesday 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference KSU Kansas City Southern / + 07/31/20 Kansas City Southern bid could be valued over $21B with debt, WSJ reports
Initiation	KemPharm initiated with a Buy at Roth Capital » 07:39 01/25/21 01/25 07:39 01/25/21 07:39 KMPH KemPharm $6.06 / +0.07 (+1.17%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options KMPH KemPharm $6.06 / +0.07 (+1.17%) 01/14/21 KemPharm announces presentations on KP415, serdexmethylphenidate 12/23/20 KemPharm announces 1-for-16 reverse stock split 12/22/20 KemPharm files IND for KP879 for treatment of stimulant use disorder 11/18/20 KemPharm, Corium to host investor event on KP415 strategy KMPH KemPharm $6.06 / +0.07 (+1.17%) 05/20/20 H.C. Wainwright KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright 03/02/21 PDUFA Date for KP415 KMPH KemPharm $6.06 / +0.07 (+1.17%) 01/21/21 Eighteen new option listings and one option delisting on January 21st 12/21/20 Four new option listings and fifteen option delistings on December 21st
Hot Stocks	Arbutus Biopharma sees cash runway into mid-2022 » 07:38 01/25/21 01/25 07:38 01/25/21 07:38 ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) Arbutus had approximately… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 07:37 Today Arbutus Biopharma announces 2021 corporate objectives 12/10/20 Arbutus Biopharma announces additional HBsAg decline data with AB-729 11/16/20 Arbutus Biopharma announces additional HBsAg decline data with AB-729 11/05/20 Arbutus Biopharma expects cash to fund operations into mid-2022 ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 12/17/20 H.C. Wainwright Arbutus Biopharma initiated with a Buy at H.C. Wainwright 09/15/20 Chardan Arbutus HBV data 'could represent a turning point,' says Chardan 07/27/20 B. Riley FBR Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR 07/24/20 Baird Arbutus Biopharma upside priced in, Baird downgrades to Neutral ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 11/05/20 Arbutus Biopharma reports Q3 EPS (27c), consensus (22c) 08/07/20 Arbutus Biopharma reports Q2 EPS (25c), consensus (24c) ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 08/07/20 Fly Intel: Pre-market Movers ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 12/15/20 Arbutus Biopharma call buyer realizes 80% same-day gains 08/18/20 Largest borrow rate increases among liquid names
Hot Stocks	Everbridge awarded statewide vaccine distribution deployment in West Virginia » 07:37 01/25/21 01/25 07:37 01/25/21 07:37 EVBG Everbridge $141.63 / -3.09 (-2.14%) Everbridge announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EVBG Everbridge $141.63 / -3.09 (-2.14%) 01/13/21 Everbridge says Mass Notification system to be used in DC 01/06/21 Everbridge receives 'important' new patent related to its Public Warning system 10/12/20 Everbridge appoints John Maeda as chief customer experience officer 09/01/20 Everbridge, Sequential Technology International announce partnership EVBG Everbridge $141.63 / -3.09 (-2.14%) 01/15/21 Credit Suisse Everbridge downgraded to Neutral at Credit Suisse as Shah assumes coverage 01/15/21 Credit Suisse Everbridge downgraded to Neutral from Outperform at Credit Suisse 11/06/20 Canaccord Everbridge price target raised to $180 from $170 at Canaccord 10/28/20 BofA Everbridge downgraded to Neutral from Buy at BofA EVBG Everbridge $141.63 / -3.09 (-2.14%) 11/05/20 Everbridge raises 2020 EPS outlook to (3c)-(1c) from (12c)-(9c) 11/05/20 Everbridge sees Q4 EPS 1c-3c, consensus 11c 11/05/20 Everbridge reports Q3 EPS 5c, consensus (11c) 08/06/20 Everbridge sees FY20 adjusted EPS (12c)-(9c), consensus (18c)

Hot Stocks	Arbutus Biopharma announces 2021 corporate objectives » 07:37 01/25/21 01/25 07:37 01/25/21 07:37 ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) Summary of 2021 Corporate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 12/10/20 Arbutus Biopharma announces additional HBsAg decline data with AB-729 11/16/20 Arbutus Biopharma announces additional HBsAg decline data with AB-729 11/05/20 Arbutus Biopharma expects cash to fund operations into mid-2022 09/15/20 Arbutus Biopharma announces AB-729 90 mg single-dose week 12 data in HBV ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 12/17/20 H.C. Wainwright Arbutus Biopharma initiated with a Buy at H.C. Wainwright 09/15/20 Chardan Arbutus HBV data 'could represent a turning point,' says Chardan 07/27/20 B. Riley FBR Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR 07/24/20 Baird Arbutus Biopharma upside priced in, Baird downgrades to Neutral ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 11/05/20 Arbutus Biopharma reports Q3 EPS (27c), consensus (22c) 08/07/20 Arbutus Biopharma reports Q2 EPS (25c), consensus (24c) ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 08/07/20 Fly Intel: Pre-market Movers ABUS Arbutus Biopharma $4.04 / +0.08 (+2.02%) 12/15/20 Arbutus Biopharma call buyer realizes 80% same-day gains 08/18/20 Largest borrow rate increases among liquid names
Recommendations	Lam Research price target raised to $650 from $450 at Credit Suisse » 07:37 01/25/21 01/25 07:37 01/25/21 07:37 LRCX Lam Research $563.92 / -0.27 (-0.05%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LRCX Lam Research $563.92 / -0.27 (-0.05%) 12/02/20 Lam Research VP Vahid Vahedi sells almost $1.3M in company shares 11/16/20 Lam Research CFO sells 8.2K shares of common stock 11/05/20 Lam Research announces $5B share repurchase authorization, quarterly dividend 08/27/20 Lam Research raises quarterly dividend 13% to $1.30 per share LRCX Lam Research $563.92 / -0.27 (-0.05%) 07:02 Today Deutsche Bank Lam Research price target raised to $575 from $500 at Deutsche Bank 06:38 Today Citi Citi moves Marvell up to pick in semiconductor equipment 06:30 Today Citi Lam Research price target raised to $660 from $420 at Citi 01/18/21 Goldman Sachs Lam Research price target raised to $616 from $557 at Goldman Sachs LRCX Lam Research $563.92 / -0.27 (-0.05%) 10/21/20 Lam Research sees Q2 EPS $5.60, +/- 40c, consensus $5.16 10/21/20 Lam Research reports Q1 EPS $5.67, consensus $5.19 10/21/20 Notable companies reporting after market close 07/29/20 Lam Research sees Q3 EPS $5.15 +/- 40c, consensus $4.14 LRCX Lam Research $563.92 / -0.27 (-0.05%) 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports LRCX Lam Research $563.92 / -0.27 (-0.05%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 07/29/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 01/27/21 Lam Research - LRCX LRCX Lam Research $563.92 / -0.27 (-0.05%) 11/27/20 Early notable gainers among liquid option names on November 27th 10/06/20 Lam Research call volume above normal and directionally bullish 09/24/20 Early notable gainers among liquid option names on September 24th 09/02/20 Lam Research call volume above normal and directionally bullish
Hot Stocks	CVS Health administered first round of COVID-19 vaccine doses » 07:35 01/25/21 01/25 07:35 01/25/21 07:35 CVS CVS Health $74.11 / +0.04 (+0.05%) CVS Health has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CVS CVS Health $74.11 / +0.04 (+0.05%) 01/11/21 CVS Health names Laurie Havanec as Chief People Officer 01/06/21 CVS Health names Michelle Peluso as first-ever Chief Customer Officer 01/06/21 CVS Health: No COVID-19 vaccines currently available at CVS Pharmacy locations 01/06/21 CVS Health administering COVID-19 vaccines in SNF's in 49 states CVS CVS Health $74.11 / +0.04 (+0.05%) 01/22/21 Baird Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird 01/19/21 JPMorgan Teladoc remains top 2021 healthcare technology pick at JPMorgan 01/08/21 Fly Intel: Top five analyst upgrades 01/08/21 Jefferies CVS Health upgraded to Buy on COVID-19 vaccination upside at Jefferies CVS CVS Health $74.11 / +0.04 (+0.05%) 11/06/20 CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27 11/06/20 CVS Health reports Q3 adj. EPS $1.66, consensus $1.33 11/05/20 Notable companies reporting before tomorrow's open 11/05/20 Notable companies reporting before tomorrow's open CVS CVS Health $74.11 / +0.04 (+0.05%) 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says 12/20/20 CDC panel says frontline workers, people over 74 should be next, NYTimes reports 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says CVS CVS Health $74.11 / +0.04 (+0.05%) 12/01/20 Fly Intel: What to watch in Salesforce's earnings report 11/17/20 Fly Intel: Wall Street's top stories at midday 11/17/20 Pharmacy owners, suppliers slide after Amazon launches new offerings 11/17/20 Fly Intel: Pre-market Movers CVS CVS Health $74.11 / +0.04 (+0.05%) 01/11/21 CVS Health call volume above normal and directionally bullish 11/17/20 Unusually active option classes on open November 17th 11/10/20 CVS Health call volume above normal and directionally bullish 11/06/20 Early notable gainers among liquid option names on November 6th
Earnings	City Holding reports Q4 EPS $1.40, consensus $1.08 » 07:35 01/25/21 01/25 07:35 01/25/21 07:35 CHCO City Holding $71.53 / +0.68 (+0.96%) The Company's net… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHCO City Holding $71.53 / +0.68 (+0.96%) 12/16/20 City Holding raises quarterly dividend to 58c from 57c per share CHCO City Holding $71.53 / +0.68 (+0.96%) 09/24/20 Boenning & Scattergood City Holding resumed with a Neutral at Boenning & Scattergood 07/09/20 Piper Sandler City Holding resumed with a Neutral at Piper Sandler CHCO City Holding $71.53 / +0.68 (+0.96%) 10/22/20 City Holding reports Q3 EPS $1.25, consensus 88c
Hot Stocks	Kimberly-Clark sees FY21 Share repurchases of $650M-$750M 07:35 01/25/21 01/25 07:35 01/25/21 07:35 KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 07:35 Today Kimberly-Clark announces 6.5% increase in quarterly dividend to $1.14 per share 07:33 Today Kimberly-Clark sees FY21 CapEx $1.2B-$1.3B 07:32 Today Kimberly-Clark announces 6.5% increase in quarterly dividend 07:31 Today Kimberly-Clark announces new $5B share repurchase program KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 01/21/21 Deutsche Bank Kimberly-Clark price target lowered to $144 from $150 at Deutsche Bank 01/19/21 Bernstein Kimberly-Clark initiated with a Market Perform at Bernstein 12/07/20 Wells Fargo Kimberly-Clark initiated with an Underweight at Wells Fargo 10/16/20 Fly Intel: Top five analyst initiations KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 07:33 Today Kimberly-Clark sees FY21 adjusted EPS $7.75-$8.00, consensus $7.77 07:30 Today Kimberly-Clark reports Q4 adjusted EPS $1.69, consensus $1.60 10/22/20 Kimberly-Clark raises FY20 net sales growth view to 2%-3% from 1%-2% 10/22/20 Kimberly-Clark raises FY20 adj. EPS view to $7.50-$7.65 from $7.40-$7.60 KMB Kimberly-Clark $132.24 / +1.14 (+0.87%) 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/22/20 Fly Intel: Wall Street's top stories for Thursday 10/22/20 Fly Intel: Wall Street's top stories at midday 10/22/20 Fly Intel: Pre-market Movers 10:00 Today Kimberly-Clark - KMB

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Chicago Fed National Activity Index: December 2020 Government Event
Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: December 2020 Government Event
CADE
Today at 08:30

Cadence Bancorp - CADE Conference Calls
SMG
Today at 09:00

The Scotts Miracle-Gro Company Firm Sponsored Meetings
KMB
Today at 10:00

Kimberly-Clark - KMB Conference Calls
OFG
Today at 10:00

OFG Bancorp - OFG Conference Calls
Today at 10:30

Dallas Fed Manufacturing Survey--General Activity Index: January 2021 Government Event
Today at 10:30

Dallas Fed Manufacturing Survey Production Index: January 2021 Government Event
FRBK
Today at 11:00

Republic First Bancorp - FRBK Conference Calls
CBU
Today at 11:00

Community Bank System - CBU Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 2.8M Shares
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $19.00-21.00 50M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $22.00-26.00 49.2M Shares ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares
Thurs	SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares
Fri	No deals

View All Syndicate Announcements »

Ionis Pharmaceuticals participates in a conference call with JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access